Skip to content

combination of intravenous bolus dexmedetomidine and intratracheal lidocaine inhibits stress responses to tracheal extubation in patients undergoing thyroid surgery under general anesthesia

combination of intravenous bolus dexmedetomidine and intratracheal lidocaine inhibits stress responses to tracheal extubation in patients undergoing thyroid surgery under general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020958
Enrollment
Unknown
Registered
2019-01-23
Start date
2019-01-18
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid surgery under general anesthesia

Interventions

control group:received a bolus dose of intravenous saline and intratracheal 3ml saline
lidcaine local anesthesia group:received a bolus dose of intravenous saline and intratracheal 3ml lidocaine(groupL)
dexmedetomidine group:received a bolus dose of intravenous dexmedetomidine and intratracheal 3ml saline(groupD)
group witha bolus dose of intravenous dexmedetomidine and intratracheal 3ml lidocaine( groupD+L):received a bolus dose of intravenous dexmedetomidine and intratracheal 3ml lidocaine( groupD+L)

Sponsors

First Anesthesiology Departement, Shengjing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with American Society of Anesthesiologists (ASA) physical status I or II; 2. Aged 17 to 75 years,male or femail; 3. Scheduled to undergo elective unilateral or total thyroidectomy.

Exclusion criteria

Exclusion criteria: 1. The presence of an upper respiratory infection symptom, asthma, difficult airway such as having a history of sleep apnea syndrome, smoking; 2. Poorly controlled hypertension (i.e., systolic blood pressure>160 mmHg or diastolic blood pressure> 90 mmHg), or active coronary artery disease, heart block, bradycardia; 3. Medication with angiotensin converting enzyme (ACE) inhibitors; 4. Mental disorders; 5. History of allergy to the drugs.

Design outcomes

Primary

MeasureTime frame
incidence and severity of coughing;Ramsay sedation scale;

Secondary

MeasureTime frame
MAP;HR;visual analogue scale (VAS);

Countries

China

Contacts

Public ContactZhiling Fu

First Anesthesiology Departement, Shengjing Hospital

18940258057@163.com+86 18940258057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026